[Taylor&Francis] An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)

kubikubiko Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-11-14 21:16

Reward30points

journal：Expert Opinion on Therapeutic Patents

Authors：Mennatallah Abdallah; Parthiena M. Keddis; Trevina M. Keddis; Dalia S. El-Gamil; Ashraf H. Abadi; Isao Kii; Matthias Engel; Mohammad Abdel-Halim

Published date：2026-8-3

DOI：10.1080/13543776.2026.2694586

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/13543776.2026.2694586

Article link：https://doi.org/10.1080/13543776.2026.2694586

Article Source：Informa UK Limited。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

kubikubiko Lv.2

Junior Member

post
reply
points
30

[Taylor&Francis] An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present) Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Taylor&Francis] An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020–present)